Drug rashes: an introduction

LAST UPDATED: Aug 19, 2021

Introduction

Approximately 2-3% of drugs result in drug rashes (and other skin changes), which are referred to as adverse cutaneous drug reactions (ACDR). This chapter predominantly signposts to mild-moderate ACDR and severe ACDR.


History

  • Approximately 2-3% of drugs result in ACDR
  • The mechanism of ACDR can be allergic or non-allergic
  • The majority are related to systemic medications but occasionally other treatments such as eye drops and inhalers can be responsible
  • Patients more at risk include older patients and those with certain underlying conditions eg HIV, SLE and Sjogren's
  • This website divides ACDR in to three groups:
    • Mild-moderate ACDR - the majority
    • Severe ACDR - this group is sometimes referred to as SCAR (serious cutaneous adverse reactions). This group includes urticaria - angioedema - anaphylaxis, the Stevens-Johnson syndrome and toxic epidermal necrolysis, the Drug Hypersensitivity syndrome (the DRESS syndrome), and erythroderma
    • Drugs associated with photosensitivity
  • For detailed information on individual drugs the Drug Eruption Reference Manual is a very useful resource

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco